NYSEAMERICAN:YCBD cbdMD (YCBD) Stock Price, News & Analysis → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free YCBD Stock Alerts $0.85 -0.05 (-5.56%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$0.85▼$0.9850-Day Range N/A52-Week Range$0.56▼$5.24Volume34,257 shsAverage Volume162,513 shsMarket Capitalization$2.59 millionP/E RatioN/ADividend YieldN/APrice Target$3.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort Interest Get cbdMD alerts: Email Address cbdMD MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside252.9% Upside$3.00 Price TargetShort InterestHealthy9.68% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.50 out of 5 stars 3.5 Analyst's Opinion Consensus RatingcbdMD has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoveragecbdMD has received no research coverage in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted9.68% of the float of cbdMD has been sold short.Short Interest Ratio / Days to CovercbdMD has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in cbdMD has recently decreased by 38.71%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldcbdMD does not currently pay a dividend.Dividend GrowthcbdMD does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for YCBD. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 2 news articles for cbdMD this week, compared to 0 articles on an average week.Search InterestOnly 1 people have searched for YCBD on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat Follows2 people have added cbdMD to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, cbdMD insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.95% of the stock of cbdMD is held by insiders.Percentage Held by InstitutionsOnly 7.18% of the stock of cbdMD is held by institutions. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of cbdMD is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of cbdMD is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatiocbdMD has a P/B Ratio of 0.27. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. About cbdMD Stock (NYSEAMERICAN:YCBD)cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.Read More YCBD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart YCBD Stock News HeadlinesApril 24, 2024 | forbes.comBest Lift Chairs For Seniors: A 2024 GuideApril 19, 2024 | americanbankingnews.comcbdMD (NYSEAMERICAN:YCBD) Trading Up 8.6%April 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.March 23, 2024 | finance.yahoo.comcbdMD, Inc. (YCBD) Stock Historical Prices & Data - Yahoo FinanceFebruary 13, 2024 | finance.yahoo.comcbdMD Reduces Year over Year Net Loss from Operations by $3.0 MillionFebruary 8, 2024 | finance.yahoo.comcbdMD, Inc. to Host Conference Call to Discuss First Quarter of Fiscal 2024 ResultsFebruary 8, 2024 | finance.yahoo.comcbdMD Welcomes Vice President of Wholesale Sales, Joe Baghadjian- Paving the Way for Future GrowthFebruary 3, 2024 | msn.comcbdMD Secures $1.25M Through Convertible Note AgreementApril 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.January 31, 2024 | finance.yahoo.comcbdMD Unveils THCV+CBG Energy Softgels, Ushering in a New Era of Wellness SolutionsJanuary 18, 2024 | finance.yahoo.comcbdMD Launches into Sprouts Farmers Market, Bringing Premium CBD Gummies to 175 Stores NationwideJanuary 15, 2024 | benzinga.comcbdMD Stock (AMEX:YCBD), Guidance and ForecastDecember 30, 2023 | markets.businessinsider.comOptimistic Outlook: Buy Rating Affirmed for cbdMD Amid Growth Initiatives and Strategic ExpansionDecember 27, 2023 | msn.comYCBD Stock Earnings: cbdMD Reported Results for Q4 2023December 26, 2023 | benzinga.comCBD Giant's Challenging Year: Q4 Net Sales Slide By 27% But Net Loss Narrows 67% YoYDecember 22, 2023 | msn.comLaidlaw cuts Cingulate to hold, cites dwindling resourcesDecember 20, 2023 | finance.yahoo.comcbdMD, Inc. to Host Conference Call to Discuss September 30, 2023 Fourth Quarter and Fiscal Year 2023 ResultsDecember 14, 2023 | finance.yahoo.comcbdMD Wins Awards in Two Categories at Prestigious Best in Biz AwardsNovember 15, 2023 | seekingalpha.comYCBD.PR.A cbdMD, Inc. 8% SER A CUM PFDOctober 25, 2023 | finance.yahoo.comcbdMD Announces Cancellation of Special MeetingOctober 6, 2023 | nasdaq.comMaxim Group Initiates Coverage of cbdMD (YCBD) with Buy RecommendationOctober 5, 2023 | benzinga.comCosta Rica's FIFA-Recognized Soccer Team Turns To CBD For Injury Prevention & HealingOctober 5, 2023 | finance.yahoo.comcbdMD Announces Historic Partnership with FIFA-Affiliated Costa Rican Soccer TeamSeptember 22, 2023 | finance.yahoo.comcbdMD Announces Adjournment of Special MeetingSeptember 22, 2023 | finance.yahoo.comBreaking Barriers: cbdMD's Research Validates Safe CBD Upper DoseSeptember 14, 2023 | finance.yahoo.comShareholders are Encouraged to Vote Well in Advance of the Proxy Deadline of 1:00 p.m. (Eastern time) on September 22, 2023August 25, 2023 | finance.yahoo.comPaw CBD Wins 2023 'Dog Hip & Joint Product of the Year' Pet Innovation AwardSee More Headlines Receive YCBD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for cbdMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/13/2024Today4/26/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorBusiness Services Industry Toilet preparations Sub-IndustryN/A Current SymbolNYSEAMERICAN:YCBD CUSIPN/A CIKN/A Webwww.cbdmd.com Phone(704) 445-3060FaxN/AEmployees52Year FoundedN/APrice Target and Rating Average Stock Price Target$3.00 High Stock Price Target$3.00 Low Stock Price Target$3.00 Potential Upside/Downside+252.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($12.63) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-22,940,000.00 Net Margins-87.07% Pretax Margin-87.07% Return on Equity-118.28% Return on Assets-81.59% Debt Debt-to-Equity RatioN/A Current Ratio1.23 Quick Ratio0.64 Sales & Book Value Annual Sales$24.16 million Price / Sales0.11 Cash FlowN/A Price / Cash FlowN/A Book Value$3.16 per share Price / Book0.27Miscellaneous Outstanding Shares3,050,000Free Float3,016,000Market Cap$2.59 million OptionableNot Optionable Beta2.15 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. T. Ronan Kennedy (Age 44)Interim CEO, Principal Executive Officer, CFO, Secretary & Treasurer Comp: $275kDr. Sibyl Swift Ph.D. (Age 43)CSO, VP of Regulatory Affairs & Director Zeb BookerChief Technology OfficerMr. John WestonDirector of Investor RelationsMr. Lance Blundell (Age 53)General Counsel Robert PettwayDirector of Public RelationsMr. Francisco Mangual (Age 45)Senior VP of Sales Ms. Shannon CharlesChief Marketing OfficerMr. David Johnson (Age 54)Senior VP of Business Development More ExecutivesKey CompetitorsSaddle Ranch MediaOTCMKTS:SRMXLeafbuyer TechnologiesOTCMKTS:LBUYLytus Technologies Holdings PTV.NASDAQ:LYTNetcapitalNASDAQ:NCPLFOXO TechnologiesNYSE:FOXOView All CompetitorsInstitutional OwnershipAXS Investments LLCBought 27,017 shares on 2/9/2024Ownership: 2.990%View All Institutional Transactions YCBD Stock Analysis - Frequently Asked Questions Should I buy or sell cbdMD stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for cbdMD in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" YCBD shares. View YCBD analyst ratings or view top-rated stocks. What is cbdMD's stock price target for 2024? 1 brokers have issued 12-month target prices for cbdMD's shares. Their YCBD share price targets range from $3.00 to $3.00. On average, they expect the company's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 252.9% from the stock's current price. View analysts price targets for YCBD or view top-rated stocks among Wall Street analysts. Are investors shorting cbdMD? cbdMD saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 226,400 shares, a drop of 38.7% from the March 31st total of 369,400 shares. Based on an average trading volume of 254,200 shares, the short-interest ratio is currently 0.9 days. Currently, 9.7% of the company's shares are short sold. View cbdMD's Short Interest. How were cbdMD's earnings last quarter? cbdMD, Inc. (NYSEAMERICAN:YCBD) announced its earnings results on Tuesday, February, 13th. The company reported ($0.67) EPS for the quarter. The company had revenue of $5.38 million for the quarter. cbdMD had a negative trailing twelve-month return on equity of 118.28% and a negative net margin of 87.07%. What ETF holds cbdMD's stock? AXS Cannabis ETF holds 37,247 shares of YCBD stock, representing 0.35% of its portfolio. When did cbdMD's stock split? cbdMD's stock reverse split on Tuesday, April 25th 2023. The 1-45 reverse split was announced on Tuesday, April 25th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, April 25th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. What other stocks do shareholders of cbdMD own? Based on aggregate information from My MarketBeat watchlists, some companies that other cbdMD investors own include KushCo (KSHB), ADMA Biologics (ADMA), Gran Tierra Energy (GTE), Novan (NOVN), Bionano Genomics (BNGO), CNBX Pharmaceuticals (CNBX), Enerplus (ERF), Matinas BioPharma (MTNB), Organigram (OGI) and Pennsylvania Real Estate Investment Trust (PEI). How do I buy shares of cbdMD? Shares of YCBD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEAMERICAN:YCBD) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding cbdMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
